City Drug House Exporters | Hepatitis Medicines Supplier to Washington, USA
City Drug House Exporters supplies and exports high-quality hepatitis medicines from India to Washington, USA with trusted pharma solutions and timely global delivery.
Natdac 60 mg (Daclatasvir), a direct-acting antiviral medication used to treat chronic hepatitis C (HCV). It works by targeting and inhibiting the viral NS5A protein, preventing the HCV virus from multiplying and spreading within liver cells.
Mechanism of Action :
NS5A Inhibition: Daclatasvir is a pangenotypic inhibitor of the hepatitis C virus (HCV) nonstructural protein 5A (NS5A), a multifunctional protein essential for viral replication and assembly.
Viral Clearance: By binding to the NS5A protein, daclatasvir interferes with both the viral RNA replication and virion assembly, ultimately leading to clearance of the virus from the blood.
Pharmacokinetics:
Bioavailability: It has an oral bioavailability of roughly 67%.
Absorption: Following a 60 mg oral dose, the drug reaches peak plasma concentrations in approximately 2 hours.
Steady State: It reaches steady-state concentrations after about 4 days of once-daily administration.
Metabolism: It is primarily metabolized in the liver by the cytochrome P450 3A4 (CYP3A4) enzyme system.
Indications & Usage :
Natdac is always prescribed in combination with other direct-acting antiviral medications (most commonly sofosbuvir, with or without ribavirin) to avoid the development of viral resistance.
It is approved for the treatment of chronic HCV genotypes 1, 3, and 4.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
